Short-term Effects Kinesiotaping (KT) on Balance and Gait in Parkinson's Disease (DP)
KT-DP
1 other identifier
interventional
10
1 country
1
Brief Summary
To analyze the short-term effect of kinesiotaping in balance and gait on Parkinson's disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Jul 2020
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2020
CompletedFirst Posted
Study publicly available on registry
March 30, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedMarch 30, 2020
March 1, 2020
1 month
March 24, 2020
March 26, 2020
Conditions
Outcome Measures
Primary Outcomes (14)
Berg Test - T0
Berg Test pre-intervention
up to week
Berg Test - T1
Berg Test post-intervention two days
up to week
Berg Test - T2
Berg Test post-intervention seven days
up to week
Tinetti Gait Test - T0
Tinetti Gait Test pre-intervention
up to week
Tinetti Gait Test - T1
Tinetti Gait Test post-intervention two days
up to week
Tinetti Gait Test - T2
Tinetti Gait Test post-intervention seven days
up to week
Up & Go Test - T0
Up \& Go Test pre-intervention
up to week
Up & Go Test - T1
Up \& Go Test post-intervention two days
up to week
Up & Go Test - T2
Up \& Go Test post-intervention seven days
up to week
Parkinson's Disease Questionnaire - T0
Parkinson's Disease Questionnaire pre-intervention
up to month
Parkinson's Disease Questionnaire - T1
Parkinson's Disease Questionnaire post-intervention
up to month
surface electromyography -T0
surface electromyography pre-intervention
up to week
surface electromyography -T1
surface electromyography post-intervention two days
up to week
surface electromyography -T2
surface electromyography post-intervention seven days
up to week
Study Arms (2)
Kinesiotaping Group
EXPERIMENTALWe used kinesiotaping (gastrocnemius and lumbar back) plus exercise
Exercise Group
ACTIVE COMPARATORWe used only exercise
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of stage III PD, according to the Hoehn and Yahr scale.
- Subjects who are in the age range of 50 to 80 years.
- Acceptance of informed consent.
- Not present a musculoskeletal disorder or other neurological disease that interferes with balance and / or walking.
- Not having a diagnosed vestibular disorder.
You may not qualify if:
- Diagnosis of parkinsonism o Parkison-Like.
- Taking medications that may interfere with the different variables evaluated.
- Allergy to any component of the bandage.
- Being a pacemaker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Javier Merino Andrés
Toledo, 45006, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2020
First Posted
March 30, 2020
Study Start
July 1, 2020
Primary Completion
August 1, 2020
Study Completion
August 1, 2020
Last Updated
March 30, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share